Relationship between increased blood pressure and hematocrit during modified ultrafiltration for pediatric open heart

Shin Takabayashi1, Hideto Shimpo, Kazuto Yokoyama

  • 1Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan. shin1111@clin.medic.mie-u.ac.jp

Insights

Modified ultrafiltration raises blood pressure and hematocrit in pediatric patients post-cardiopulmonary bypass. However, hemoconcentration does not appear to be the primary driver of this blood pressure increase.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Modified ultrafiltration (MUF) is a technique used after cardiopulmonary bypass (CPB) to improve hemodynamics in pediatric patients.
  • The precise mechanism by which MUF increases blood pressure remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between increased blood pressure and hematocrit following CPB in pediatric patients undergoing ventricular septal defect closure.
  • To determine if hemoconcentration is the primary cause of the observed hemodynamic improvement with MUF.

Main Methods:

  • A retrospective analysis of 30 pediatric patients undergoing ventricular septal defect closure was performed.
  • Patients were divided into two groups: modified ultrafiltration (n=15) and conventional ultrafiltration (n=15).
  • Intraoperative blood pressure and hematocrit were compared, with correlations analyzed between blood pressure and hematocrit changes.

Main Results:

  • Modified ultrafiltration led to significant increases in hematocrit and systolic blood pressure in the MUF group.
  • Patients in the MUF group exhibited higher diastolic and mean blood pressure post-CPB compared to the conventional group.
  • No significant correlation was found between blood pressure increases and hematocrit levels, either overall or in terms of percent change.

Conclusions:

  • Modified ultrafiltration effectively increases blood pressure and hematocrit in pediatric patients after CPB.
  • The study suggests that hemoconcentration is not the main factor responsible for the blood pressure elevation observed with MUF.
  • Further research is needed to elucidate the exact mechanisms driving the hemodynamic benefits of MUF.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...